Retraction Note: Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Retraction Notice: Comprehensive Multi-Omics Investigation of Genomic, Epigenomic, and Transcriptomic Profiles for Identifying Molecular Subtypes and Key Genes in Lung Adenocarcinoma

  • By

  • Yue Zhao

  • Yakun Gao

  • Xiaodong Xu

  • Jiwu Zhou

  • He Wang

  • July 9, 2026

Share

Objective:

To investigate genomic, epigenomic, and transcriptomic profiles in lung adenocarcinoma.

Key Findings:
  • Concerns were raised about data integrity in the article, specifically regarding similarities detected in figures.
  • Similarities were noted between specific panels in Fig. 13A and Fig. 13B.
  • The authors did not respond to inquiries regarding these concerns.
Interpretation:

The Editors have lost confidence in the data and conclusions of the article due to unresolved issues.

Limitations:
  • Lack of author response to concerns raised about data integrity.
  • Identified issues in multiple figures that raised questions about the validity of the findings.
Conclusion:

The article has been retracted due to concerns about data reliability.

Sources:

Original Source(s)

Retraction Note: Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma

  • by Yue Zhao, Yakun Gao, Xiaodong Xu, Jiwu Zhou, He Wang

  • July 9, 2026

Related Content

Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

Cost-Effectiveness of Smoking Cessation Interventions Integrated Into Lung Cancer Screening

AI-Designed Binder Improves CAR T Cell Activity in Mice

Researchers screened 1,758 de novo protein binders and identified design features that influence CAR T cell activation, specificity, and tumor control

  • September 15, 2026

  • 3 min